Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

204 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of revascularization of a chronic total coronary occlusion on electrocardiographic variables. A sub-study of the EXPLORE trial.
van Dongen IM, Kolk MZH, Elias J, Meijborg VMF, Coronel R, de Bakker JMT, Claessen BEPM, Delewi R, Ouweneel DM, Scheunhage EM, van der Schaaf RJ, Suttorp MJ, Bax M, Marques KM, Postema PG, Wilde AAM, Henriques JPS. van Dongen IM, et al. Among authors: suttorp mj. J Electrocardiol. 2018 Sep-Oct;51(5):906-912. doi: 10.1016/j.jelectrocard.2018.07.012. Epub 2018 Jul 19. J Electrocardiol. 2018. PMID: 30177338 Free article. Clinical Trial.
Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases.
van Werkum JW, Heestermans AA, de Korte FI, Kelder JC, Suttorp MJ, Rensing BJ, Zwart B, Brueren BR, Koolen JJ, Dambrink JH, van't Hof AW, Verheugt FW, ten Berg JM. van Werkum JW, et al. Among authors: suttorp mj. Circulation. 2009 Feb 17;119(6):828-34. doi: 10.1161/CIRCULATIONAHA.108.799403. Epub 2009 Feb 2. Circulation. 2009. PMID: 19188507
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial.
Claessen BE, Beijk MA, Legrand V, Ruzyllo W, Manari A, Varenne O, Suttorp MJ, Tijssen JG, Miquel-Hebert K, Veldhof S, Henriques JP, Serruys PW, Piek JJ. Claessen BE, et al. Among authors: suttorp mj. Circ Cardiovasc Interv. 2009 Aug;2(4):339-47. doi: 10.1161/CIRCINTERVENTIONS.108.831800.108.831800. Epub 2009 Jul 22. Circ Cardiovasc Interv. 2009. PMID: 20031737 Free article. Clinical Trial.
Rationale and design of EXPLORE: a randomized, prospective, multicenter trial investigating the impact of recanalization of a chronic total occlusion on left ventricular function in patients after primary percutaneous coronary intervention for acute ST-elevation myocardial infarction.
van der Schaaf RJ, Claessen BE, Hoebers LP, Verouden NJ, Koolen JJ, Suttorp MJ, Barbato E, Bax M, Strauss BH, Olivecrona GK, Tuseth V, Glogar D, Råmunddal T, Tijssen JG, Piek JJ, Henriques JP; EXPLORE investigators. van der Schaaf RJ, et al. Among authors: suttorp mj. Trials. 2010 Sep 21;11:89. doi: 10.1186/1745-6215-11-89. Trials. 2010. PMID: 20858263 Free PMC article. Clinical Trial.
5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
Vink MA, Dirksen MT, Suttorp MJ, Tijssen JG, van Etten J, Patterson MS, Slagboom T, Kiemeneij F, Laarman GJ. Vink MA, et al. Among authors: suttorp mj. JACC Cardiovasc Interv. 2011 Jan;4(1):24-9. doi: 10.1016/j.jcin.2010.11.003. JACC Cardiovasc Interv. 2011. PMID: 21251625 Free article. Clinical Trial.
Patency of paclitaxel-eluting versus bare metal stents long term after implantation in acute ST-segment elevation myocardial infarction.
Vink MA, Van Nooijen FC, Laarman GJ, Suttorp MJ, Tijssen JG, Slagboom T, Patterson MS, Van Der Schaaf RJ, Kiemeneij F, Amoroso G, Dirksen MT. Vink MA, et al. Among authors: suttorp mj. Am J Cardiol. 2011 Nov 1;108(9):1214-9. doi: 10.1016/j.amjcard.2011.06.034. Epub 2011 Aug 23. Am J Cardiol. 2011. PMID: 21864813 Clinical Trial.
Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study).
Van den Branden BJ, Rahel BM, Laarman GJ, Slagboom T, Kelder JC, Ten Berg JM, Suttorp MJ. Van den Branden BJ, et al. Among authors: suttorp mj. EuroIntervention. 2012 Feb;7(10):1189-96. doi: 10.4244/EIJV7I10A190. EuroIntervention. 2012. PMID: 22030323 Free article. Clinical Trial.
A randomized multicenter comparison of hybrid sirolimus-eluting stents with bioresorbable polymer versus everolimus-eluting stents with durable polymer in total coronary occlusion: rationale and design of the Primary Stenting of Occluded Native Coronary Arteries IV study.
Teeuwen K, Adriaenssens T, Van den Branden BJ, Henriques JP, Van der Schaaf RJ, Koolen JJ, Vermeersch PH, Bosschaert MA, Tijssen JG, Suttorp MJ. Teeuwen K, et al. Among authors: suttorp mj. Trials. 2012 Dec 15;13:240. doi: 10.1186/1745-6215-13-240. Trials. 2012. PMID: 23241457 Free PMC article. Clinical Trial.
Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III): a randomised comparison of sirolimus-eluting stent implantation with zotarolimus-eluting stent implantation for the treatment of total coronary occlusions.
Van den Branden BJ, Teeuwen K, Koolen JJ, van der Schaaf RJ, Henriques JP, Tijssen JG, Kelder JC, Vermeersch PH, Rensing BJ, Suttorp MJ. Van den Branden BJ, et al. Among authors: suttorp mj. EuroIntervention. 2013 Nov;9(7):841-53. doi: 10.4244/EIJV9I7A138. EuroIntervention. 2013. PMID: 23628457 Free article.
204 results